Characterizing Dissemination in Spinal Tuberculosis Using Whole-Body PET/CT
Overview
Whole-body FDG-PET/CT increased detection of disseminated spinal tuberculosis from 40% to 60%, highlighting its sensitivity in identifying disease extent. However, the nonspecific nature of FDG uptake and unclear impact on clinical management raise concerns about overestimation and practical utility.
Background
Spinal tuberculosis (STB) is a serious extrapulmonary manifestation of tuberculosis that can lead to significant morbidity. Accurate assessment of disease dissemination is critical for guiding treatment strategies. Conventional imaging may underestimate disease burden, prompting investigation into advanced modalities like whole-body FDG-PET/CT. This imaging technique detects metabolic activity but may also capture non-specific inflammatory changes.
Data Highlights
The study reported an increase in detected dissemination from 40% to 60% when incorporating PET/CT findings. Quantitative PET parameters such as SUVmax and total lesion glycolysis were measured, representing novel biomarkers in spinal infections, though their clinical relevance remains to be established.
Key Findings
Definition of disseminated STB combined microbiological confirmation with FDG-avid lesions on PET/CT, including those without culture positivity.
FDG uptake is nonspecific and may reflect inflammation or inactive disease, potentially leading to overestimation of dissemination.
Whole-body PET/CT identified a higher disease burden but the impact on clinical management decisions was not demonstrated.
Quantitative PET metrics like SUVmax and total lesion glycolysis were reported but require further validation against clinical outcomes.
Routine use of PET/CT is limited by cost, availability, and uncertain incremental clinical benefit in high TB-burden settings.
Clinical Implications
Clinicians should interpret PET/CT findings with caution due to potential nonspecific FDG uptake and the risk of overestimating disease dissemination. While PET/CT can reveal additional lesions, its influence on treatment decisions remains unclear, underscoring the need for further validation and correlation with clinical outcomes before routine adoption.
Conclusion
Whole-body FDG-PET/CT enhances detection of disseminated spinal tuberculosis but may overestimate disease extent due to nonspecific uptake. Further studies are needed to clarify its prognostic value and impact on clinical management.
References
Original Study on PET/CT in Spinal Tuberculosis
FDG Uptake Specificity in Infectious and Inflammatory Diseases
